Kou M. Hwang

774 total citations
17 papers, 631 citations indexed

About

Kou M. Hwang is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Kou M. Hwang has authored 17 papers receiving a total of 631 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Immunology. Recurrent topics in Kou M. Hwang's work include Monoclonal and Polyclonal Antibodies Research (6 papers), Toxin Mechanisms and Immunotoxins (5 papers) and Glycosylation and Glycoproteins Research (4 papers). Kou M. Hwang is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (6 papers), Toxin Mechanisms and Immunotoxins (5 papers) and Glycosylation and Glycoproteins Research (4 papers). Kou M. Hwang collaborates with scholars based in United States and India. Kou M. Hwang's co-authors include Alan C. Sartorelli, Sandra A. Murphree, Robert K. Oldham, Jeffrey D. Lifson, Lee E. Eiden, Blair A. Fraser, Nancy M. Dunlop, Peter L. Nara, Kenneth A. Foon and Marc E. Key and has published in prestigious journals such as Science, The Journal of Cell Biology and Biochemical Pharmacology.

In The Last Decade

Kou M. Hwang

17 papers receiving 560 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kou M. Hwang United States 13 260 187 178 127 111 17 631
Gert Hausdorf Germany 16 449 1.7× 257 1.4× 320 1.8× 81 0.6× 53 0.5× 32 1.0k
J.P. Priestle Switzerland 10 603 2.3× 88 0.5× 210 1.2× 137 1.1× 31 0.3× 15 1.0k
Bernard Bayard France 20 815 3.1× 74 0.4× 224 1.3× 93 0.7× 45 0.4× 44 1.1k
Scott W. Reid United Kingdom 9 407 1.6× 191 1.0× 563 3.2× 150 1.2× 99 0.9× 13 996
William B. McCombs United States 10 585 2.3× 119 0.6× 129 0.7× 418 3.3× 35 0.3× 15 1.1k
Patricia K. Lumma United States 15 439 1.7× 84 0.4× 38 0.2× 143 1.1× 184 1.7× 20 959
Åsa Frostell United Kingdom 12 582 2.2× 262 1.4× 205 1.2× 339 2.7× 31 0.3× 17 913
J L Winkelhake United States 15 331 1.3× 234 1.3× 340 1.9× 127 1.0× 17 0.2× 21 893
Jeffry D. Watkins United States 15 627 2.4× 427 2.3× 160 0.9× 99 0.8× 14 0.1× 24 958
Himadri Samanta United States 19 676 2.6× 64 0.3× 393 2.2× 244 1.9× 268 2.4× 35 1.2k

Countries citing papers authored by Kou M. Hwang

Since Specialization
Citations

This map shows the geographic impact of Kou M. Hwang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kou M. Hwang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kou M. Hwang more than expected).

Fields of papers citing papers by Kou M. Hwang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kou M. Hwang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kou M. Hwang. The network helps show where Kou M. Hwang may publish in the future.

Co-authorship network of co-authors of Kou M. Hwang

This figure shows the co-authorship network connecting the top 25 collaborators of Kou M. Hwang. A scholar is included among the top collaborators of Kou M. Hwang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kou M. Hwang. Kou M. Hwang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Rausch, Dianne M., et al.. (1992). CD4(81–92)-based peptide derivatives. Biochemical Pharmacology. 43(8). 1785–1796. 10 indexed citations
2.
Lifson, Jeffrey D., Kou M. Hwang, Peter L. Nara, et al.. (1988). Synthetic CD4 Peptide Derivatives That Inhibit HIV Infection and Cytopathicity. Science. 241(4866). 712–716. 146 indexed citations
3.
Hwang, Kou M., Øystein Fodstad, Robert K. Oldham, & Adrienne Morgan. (1985). Radiolocalization of xenografted human malignant melanoma by a monoclonal antibody (9.2.27) to a melanoma-associated antigen in nude mice.. PubMed. 45(9). 4150–5. 34 indexed citations
4.
Hwang, Kou M., et al.. (1984). Selective antitumor effect on L10 hepatocarcinoma cells of a potent immunoconjugate composed of the A chain of abrin and a monoclonal antibody to a hepatoma-associated antigen.. PubMed. 44(10). 4578–86. 51 indexed citations
5.
Hwang, Kou M., et al.. (1984). Analysis of the involvement of cells from donor and recipient mice in adoptive transfer of antitumor immunity.. PubMed. 44(12 Pt 1). 5491–8. 4 indexed citations
6.
Bernhard, Michael, Kenneth A. Foon, Thomas N. Oeltmann, et al.. (1983). Guinea pig line 10 hepatocarcinoma model: characterization of monoclonal antibody and in vivo effect of unconjugated antibody and antibody conjugated to diphtheria toxin A chain.. PubMed. 43(9). 4420–8. 53 indexed citations
7.
Weinstein, John N., Michael A. Steller, Andrew M. Keenan, et al.. (1983). Monoclonal Antibodies in the Lymphatics: Selective Delivery to Lymph Node Metastases of a Solid Tumor. Science. 222(4622). 423–426. 62 indexed citations
8.
Bernhard, Michael, Kou M. Hwang, Kenneth A. Foon, et al.. (1983). Localization of 111In- and 125I-labeled monoclonal antibody in guinea pigs bearing line 10 hepatocarcinoma tumors.. PubMed. 43(9). 4429–33. 26 indexed citations
9.
Lazo, John S., Kou M. Hwang, & Alan C. Sartorelli. (1977). Inhibition of L-fucose incorporation into glycoprotein of Sarcoma 180 ascites cells by 6-thioguanine.. PubMed. 37(12). 4250–5. 14 indexed citations
10.
Murphree, Sandra A., et al.. (1976). Effects of adriamycin on surface properties of sarcoma 180 ascites cells. Biochemical Pharmacology. 25(10). 1227–1231. 100 indexed citations
11.
Hwang, Kou M. & Alan C. Sartorelli. (1975). Use of plant lectin-induced agglutination to detect alterations in surface architecture of sarcoma 180 caused by antineoplastic agents. Biochemical Pharmacology. 24(10). 1149–1152. 5 indexed citations
12.
Tsiftsoglou, Asterios S., Kou M. Hwang, Krishna C. Agrawal, & Alan C. Sartorelli. (1975). Strand-scission of Sarcoma 180 tumor cell DNA induced by 1-formylisoquinoline thiosemicarbazone. Biochemical Pharmacology. 24(17). 1631–1633. 16 indexed citations
13.
Hwang, Kou M., Sandra A. Murphree, & Alan C. Sartorelli. (1974). A quantitative spectrophotometric method to measure plant lectin-induced cell agglutination.. PubMed. 34(12). 3396–402. 24 indexed citations
14.
Hwang, Kou M., Sandra A. Murphree, & Alan C. Sartorelli. (1974). Differential effects of urethan on the transcriptional activity of chromatin from regenerating liver.. PubMed. 34(4). 783–7. 5 indexed citations
15.
Hwang, Kou M., Sandra A. Murphree, Charles W. Shansky, & Alan C. Sartorelli. (1974). Sequential biochemical events related to DNA replication in the regenerating rat liver. Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis. 366(2). 143–148. 15 indexed citations
16.
Hwang, Kou M., Linda Yang, Christine K. Carrico, et al.. (1974). PRODUCTION OF MEMBRANE WHORLS IN RAT LIVER BY SOME INHIBITORS OF PROTEIN SYNTHESIS. The Journal of Cell Biology. 62(1). 20–31. 48 indexed citations
17.
Hwang, Kou M., Sandra A. Murphree, & Alan C. Sartorelli. (1973). The effect of urethan on the incorporation of thymidine-3H into DNA and the activities of some enzymes required for DNA biosynthesis in rat regenerating liver.. PubMed. 33(9). 2149–55. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026